BlueYard Knowledge

  1. Home
  1. Latest
  2. Events
  3. Portfolio Updates
  4. Live-Coding
  5. BlueYard
  6. Deep-Dives
  1. The Technology Behind Web 3: Live Coding with Massa

    2023-06-01
    - file://osMRMqawJEE2peXT

    A live-coding stream with Massa, showcasing a fully on-chain autonomous trading bot powered by Massa’s autonomous smart contracts. The bot will be built on Dusa, the first fully autonomous DEX also powered by autonomous smart contracts and hosted on-chain.

    1. autonomous smart contracts
  2. Enabling The Next Generation of Spin-Outs: BlueYard × Nucleate

    2023-05-24
    - file://wh3fS0GerBFFa8GT

    To help foster a dialogue about enabling the next generation of university spin-outs, BlueYard and Nucleate teamed up to host an evening of conversations over dinner in London for an intimate group of scientsts, entrepreneurs, and policy-makers …

    1. bio
  3. Sensible Bio

    2023-04-06
    - file://4qSvoilcSFbkQvIh

    The unprecedented speed and success of mRNA vaccines in tackling the COVID-19 pandemic has underscored the demand for mRNA as a next-generation nucleic acid therapy …

    1. biology
  4. The Technology Behind Web3: The FileCoin Virtual Machine

    2023-03-31
    - file://CBkzGPs2zDx68V5T

    A live-coding stream with the FVM team on creating NFTs on FEVM (using stable diffusion), and a walkthrough of Lilypad, which is creating a new model for ethical AI-art creation …

  5. If Web3 is to Work … A BlueYard Conversation

    2023-03-02
    - file://tmFnKm3og6O1PXE0

    To help facilitate a discussion about what needs to change If Web3 Is To Work (and to gain real and sustainable adoption in the next wave), BlueYard is hosting a day of lightning talks and conversations …

    1. crypto
  6. Expression Edits

    2023-02-20
    - file://Hx6SeRbEuKhrfq09

    Proteins are a foundational pillar in healthcare and behind every major advancement in biotech and synthetic biology for the last half-century, while biotech’s emergence as a new class of therapeutics was driven by the ability to produce proteins using cells or organisms in a controlled manner.

  7. Housecat

    2023-02-16
    - file://K0wV4cFVmiV8D3iI

    Despite its promise, crypto — and in particular DeFi — takes a lot of time and energy to understand, and remains hard to navigate safely. From the new vocabulary to the ‘untraditional’ finance values of anonymity to complex wallet set-ups and frothy markets, many prospective new crypto investors do not know where to start …

    1. crypto
  8. Shell Protocol

    2023-02-06
    - file://3iyp2e220QWwGUM6

    If DeFi is to achieve its end goal of being a secure, permissionless, always-on system, it will need to be simpler to build, cheaper, faster, and more secure than its current state. With its focus on simplifying DeFi smart contract development, making transactions less cumbersome, and improving overall UX, Shell Protocol could be an important step towards this future …

    1. Web3
  9. Corintis

    2023-02-01
    - file://QRfeDnCbF2p5h0SQ

    For more than 50 years, the technology industry benefited from the tail winds of Moore’s Law. The density of transistors in a silicon microprocessor doubled roughly every 2 years. Up until 10 years ago, that meant that microprocessors got twice as fast every 2 years …

  10. Creasallis

    2023-01-26
    - file://GJ3WhdIBziGo9skK

    Creasallis is developing its own antibody engineering platform, CreaTap, aimed at improving the penetration of antibodies into the tumor microenvironment while ensuring a long enough half-life to provide the best of mAbs and antibody fragments.

  11. Join Our Team as a Bio + Health focused Principal

    2023-01-25
    - file://AqIe4Uyx5JYnEGLa

    We are excited to be expanding the BlueYard team with a Principal position, either remote or based in Berlin, supporting the team in finding and backing entrepreneurs that are decentralizing markets and empowering humanity.

  12. BlueYard × Nucleate Partnership

    2023-01-16
    - file://XE9Mj2DeWd67zImr

    As part of our goal to foster more innovation at the frontiers of science and technology at the earliest stages, today we are announcing our newest collaboration by partnering with Nucleate, a student-led non-profit organization dedicated to empowering the next generation of biotech leaders

  • more recently
  • earlier
  1. Knowledge.BlueYard | 2025